Popular Keywords
- About Us
-
Research Report
Research Directory
Semiconductors
LED
Consumer Electronics
Emerging Technologies
- Selected Topics
- Membership
- Price Trends
- Press Center
- News
- Events
- AI Agent
Precision medicine is one of the hottest field within the biotechnology sector and has attracted considerable investments by national governments worldwide. The basis of development in the field of precision medicine is gene sequencing. “Owing to major initiatives in many countries, the global market scale of next-generation sequencing (NGS) instruments and reagents will expand rapidly at a CAGR of 13.5% in the 2015~2020 period, from US1.8 billion to US$3.35 billion,” said Sean Liu, biotechnology analyst for TrendForce.
Sony’s PlayStation VR (PS VR) immediately achieved sold-out status following its release on October 13. The event signaled the start of a new round of competition in the global VR device market in the fourth quarter of 2016. “Demand for VR devices will remain quite strong in the next two years,” said Jason Tsai, wearable device analyst for TrendForce. “Conversely, product shipments will not keep pace with the demand. Shortages of key components, particularly OLED panels, will prevent device makers from putting more products on the shelves.”
The scale of the global hepatitis B drug market was around US$2.15 billion in 2015 and is forecast to grow slowly at a CAGR of just 0.4% to US$2.2 billion in 2023, according to the latest biotechnology report from the global market research firm TrendForce.
With download and active user numbers far exceeding other popular apps, Nintendo’s Pokémon GO has generated an enormous wave of enthusiasm for mobile gaming and augmented reality (AR) technology worldwide. According to the latest analysis from the global market research firm TrendForce, the revenue from Pokémon GO is forecast to top US$800 million in 2017. The game is set to become a significant contributor to the expansion of the global AR software market, which will reach US$30 billion in scale by 2020.
Aging population and rising costs of new drugs have increased healthcare expenses in countries across the globe and spurred governments to expand the use of generic drugs. Currently, there are factors constraining the development of generics. The U.S., for instance, is pushing the international adoption of patent linkage via the Trans-Pacific Partnership (TPP) and Bilateral Free Trade Agreements (BFTAs).
